Synthesis of Carum Carvi essential oil nanoemulsion, the cytotoxic effect, and expression of caspase 3 gene

Journal of Food Biochemistry
Niloufar KhatamianAtieh Darchini Maragheh

Abstract

Scientists are attempting to find novel methods to overcome cancers. Nanoemulsion systems as the novel drug delivery tools have been widely used in cancer therapy. In this study, the Carum Carvi oil nanoemulsions (CCONE) were prepared and its cytotoxic activity was studied on human colon cancer HT-29 cells using MTT assay. Flow cytometry and Real-time qPCR were triggered to evaluate the nanoemulsions' apoptotic properties. The results showed a significant negative association between the HT-29 cancer cell viability and CCONE doses of treatments compared with Huvec normal cells (p value < 0.001). The IC50 values were estimated 12.5 µg/ml and 50 µg/ml for HT-29 and Huvec, respectively. Moreover, we observed that increasing concentrations of nanoemulsions significantly upregulate Caspase-3 gene expression. The results showed the CCONE is an efficient novel apoptosis inducer for human colon cancer cells without any undesirable side effects. However, further in vitro and in vivo researches are required. PRACTICAL APPLICATIONS: Cancer is a complex and usually untreatable disorder. Several types of cancer therapy strategies have been applied widely to overcome cancers. Chemotherapy has been used in various types of cancers. In most ca...Continue Reading

References

Mar 31, 2000·Experimental Cell Research·S Nagata
Apr 10, 2004·Advances in Colloid and Interface Science·O Sonneville-AubrunF L'Alloret
Apr 10, 2004·Advances in Colloid and Interface Science·Tharwat TadrosC Solans
May 15, 2004·The Journal of Pharmacy and Pharmacology·Allyne Carvalho de SousaCerli Rocha Gattass
Jan 30, 2007·The Journal of Surgical Research·Sergio HuertaEdward H Livingston
Feb 29, 2008·BMB Reports·Song Iy HanTae-Hyoung Kim
Sep 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jonathan F Tait
Apr 7, 2010·PloS One·Ertugrul DalkicChristina Chan
Feb 22, 2011·Advanced Drug Delivery Reviews·Rubi MahatoKun Cheng
Jul 24, 2012·Talanta·José Luis Burguera, Marcela Burguera
Jan 16, 2013·Chemotherapy Research and Practice·Katrin Sak
Mar 5, 2013·Journal of Colloid and Interface Science·Elijah NazarzadehShahriar Sajjadi
Jun 5, 2014·Natural Product Research·Boris PejinGordana Bogdanovic
Jun 28, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Anna Rita BiliaMaria Camilla Bergonzi
Mar 12, 2016·Ultrasonics Sonochemistry·Vaiyapuri Subbarayan PeriasamyAli A Alshatwi
Jul 9, 2016·International Journal of Pharmaceutics·Virginia CampaniGiuseppe De Rosa
Jul 16, 2016·Journal of Biotechnology·Francesco Donsì, Giovanna Ferrari
Nov 2, 2016·Current Pharmaceutical Design·Megumi Nishitani YukuyamaNadia Araci Bou-Chacra
Mar 11, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuvraj SinghManish K Chourasia
Apr 27, 2017·International Journal of Nanomedicine·Hossein JahangirianYadollah Abdollahi

❮ Previous
Next ❯

Citations

Aug 11, 2020·Frontiers in Pharmacology·Ce TangGang Fan
Dec 30, 2020·Progress in Lipid Research·David Julian McClements

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis